Stocks
Blueprint Medicines Corporation (BPMC) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -543.2% | 38.9% | -356.5% | -263.4% | -190.3% | -154.0% | ||
| Changes by years, y/y, % | -12pp | +582pp | -395pp | +93pp | +73pp | -18.6% | |||
Blueprint Medicines Corporation. EBITDA margin, %
Blueprint Medicines Corporation. EBITDA margin, changes, pp
Blueprint Medicines Corporation (BPMC) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -194.7% | -222.3% | -228.0% | -143.9% | -77.0% | -154.0% | |
| Changes by years, y/y, % | -29pp | +205pp | -42pp | +242pp | +118pp | |||
| Changes by quarters, q/q, % | +192pp | -28pp | -6pp | +84pp | +67pp | |||
